Dr. Campbell is an anatomic pathologist with specialization in neuropathology. His diagnostic experience includes all areas of surgical neuropathology, including neoplasia and neuromuscular disease, and both general and neuropathologic autopsy examination. He has experience in the histology of viral encephalitis, having previously worked with various virologists on models of viral disease including Sindbis virus, Japanese encephalitis, West Nile encephalitis, Venezuelan equine encephalitis, H5N1 influenza and others.  He also has research interests in genetic central nervous system diseases such as Canavan’s disease and in diseases related to injury of the blood-brain barrier, including especially cerebral small vessel disease.

Genetic central nervous system diseases such as Canavan’s disease and in diseases related to injury of the blood-brain barrier, Including especially cerebral small vessel disease.

Stavros J Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine, Aristotelian University, Thessaloniki, Greece Postgraduate training (a) Neurology, Aristotelian University and Institute of Neurology, Queen Square, London, (b) Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia (c) Neurootology and Neuropathology of Auditory pathway in Harvard University, (d)Neuropathology and Experimental Neurology, University of Pennsylvania, (e) Neuroimmunology, Yale University, New Haven. Research on Blood Brain Barrier in dementias and Demyelinating diseases, Mitochondria in Alzheimer’s disease, Synaptogenesis in vivo and in vitro, Neuronal apoptosis in dementias and demyelinating diseases, Dendritic pathology in dementias, Pathology of Golgi apparatus in dementias. Member of 56 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for Health and medical education in Africa. Visiting professor in Tufts University, Democretian University, Thrace, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 text books on Neurology, Neuropathology, Neuropsychology and of 692 papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neuroethics. In 2014 he published a book of poems. Head of the 1^st Department of Neurology, Aristotelian University (1992-2011). Emeritus Professor of Neurology, Aristotelian University, Thessaloniki, Greece. Director of Research Institute for Alzheimer’s disease and ageing.

Neuroethics; Neurolinguistics; Philosophy of Neurosciences; Application of Mathematics in Neurosciences; Neurology and the Art.

Brent is a neuropathologist/neuroscientist with a primary interest to investigate the pathogenesis and pathophysiology of several neurological diseases with the goal of discovering new mechanisms and targets for drug therapy. His graduate training in neuropharmacology combined withhis medical training in neuropathology has allowed me to approach such diseases/conditions as FTLD, ALS, prion disease, Traumatic Brain Injury, Alzheimer’s disease and CNS neoplasia with an eye towards translation of basic mechanisms of disease into therapy.  A major goal of his laboratory is to understand how neuroinflammation and glial-neuronal signaling may be important in CNS biology and disease.

Cellular/molecular neurobiology and neuropathology.

The complex nature of glial-neuronal interactions/communication and molecular mechanisms in the context of neuropathological diseases including use of SOD1 transgenic rodent models

Liang received her MD from Xiangya School of Medicine in Hunan, China and PhD in Biochemistry and Biophysics from Oregon State University.  She completed her Residency in Anatomic Pathology and Clinical Pathology at University of Massachusetts Medical School, followed by a Fellowship in Gynecologic Pathology at Yale University School of Medicine.  She worked at Stony Brook University Hospital as an attending pathologist and was an Associate Professor at Stony Brook University Medical Center.  Currently she is a Chief of Gynecologic Pathology Service at the Department of Pathology and Laboratory Medicine at North Shore-LIJ Health System and an Associate Professor of Hofstra North Shore-LIJ School of Medicine.

Clinicopathological Studies of Gynecologic Malignancies; Especially Endometrial and Ovarian Cancers.

George Perry is dean of the College of Sciences and professor of biology at The University of Texas at San Antonio. He is recognized in the field of Alzheimer disease research particularly for his work on oxidative metabolism. He received his bachelor's of arts degree in zoology with high honors from University of California Santa Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures. In 1982, he joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer’s disease researchers with over 900 publications, one of the top 100 most-cited scientists in neuroscience and behavior. He has been cited over 58,000 times (H=120) and is recognized as an ISI highly cited researcher. He is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Chemistry (CChem), Royal Society of Medicine, Royal College of Pathologists, Society of Biology (CBio, CSci) and the Linnean Society of London, past-president of the American Association of Neuropathologists, Foreign Correspondent member of the Spanish Royal Academy of Sciences, Foreign Corresponding member of the Academy of Sciences of Lisbon, Corresponding member of the Mexican Academy of Sciences and member of the Iberoamerican Molecular Biology Organization. He won the Distinguished Professional Mentor award from the Society for the Advancement of Chicanos and Native Americans in Sciences, Senior Investigator Award of the International College of Geriatric Psychoneuropharmacology, Senior Fulbright Fellow and the Panama National Plaque of Honor for Excellence in Neuroscience.

Alzheimer disease develops and it’s physiological consequences at cellular level and the sequence of events leading to damage caused by and the source of metabolic abnormalities.

Alexey Glazyrin Born in 1961 in Vladivostok, USSR
Graduated for Novosibirsk State Medical School, USSR in 1985 (MD)
Graduated from Novosibirsk Institute of Clinical and Experimental Therapy, Novosibirsk, USSR in 1988 (PhD)
Worked as Pathologist/Research scientist Institute of Pediatrics, Irkutsk, Russia till 1988-1995
Postdoctoral Fellowship in molecular pathology in Edinburgh University, Edinburgh, Scotland 1995-1999
Postdoctoral Fellow/ research scientist in Karmanos Cancer Institute, Detroit, USA 1999-2003
Research scientist, AsterandInc, Detroit USA 2003-2006
Pathology residency, AP/CP Pathology, Albany Medical Center, Albany USA 2006-2010
Hematopathology Fellowship, Beaumont Hospital, Detroit USA 2010-2011
Director of Hematopathology, Assistant Professor in UMKC, Truman Medical Center, Kansas City USA, 2011-present
 

Pathology, Hematopathology, Neuropathology, Flow Cytometry, Synchrotron  Radiation, novel methods of tissue staining, Diffuse Large B Cell Lymphoma,  Antitumor immunization.

Biography

Nallasivam Palanisamyresearch career began at the Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India, as a graduate student working on understanding the genetic basis of congenital heart diseases using epidemiological and cytogenetic approaches. As a postdoctoral research associate where he isolated and characterized human smooth muscle myosin heavy chain isoforms and studied their role as molecular markers in vascular development and atherosclerosis. In 1996 he had the opportunity to join the laboratory of Dr. Raju Chaganti at the Memorial Sloan Kettering Cancer Center, New York USA. He was involved in the cloning and characterization of several immunoglobulin heavy chain genes (IGH) associated with chromosomal translocations and cognate gene fusions (IGH-MUC1; IGH-FGFR2; IGH IRTA1-2; IGH-CHST11; IGH-PAX5).

In 1999, he accepted a position as Director of Research and Development at Cancer Genetics, Inc, Boston, MA. Two patents have been granted recently (US patents #7585964; 7964345) for the novel approaches he developed for analyzing chromosomal translocations using fluorescence in situ hybridization. Utilizing the newly developed tools, a novel recurrent gene fusion involving CD44-SLC1A2 genes was discovered, the results of which were published in Science Translational Medicine.

 Here, his efforts are focused on identifying new cancer biomarkers in epithelial cancers. Following the discovery of recurrent gene fusions in prostate cancer by Arul Chinnaiyan’s group in a subset of prostate cancer, He discovered recurrent gene fusions involving the RAF kinase family genes that could potentially be targeted with existing FDA approved drugs and may benefit a subset of prostate cancer patients. By extending the screening for the presence of RAF gene fusions in other epithelial cancers, a small subset of melanoma and gastric cancers were also found to harbor RAF kinase rearrangements..

Application of new high throughput technologies in genome research for the discovery of gene fusions in cancer.

Development of diagnostic reagents based on fluorescence in situ hybridization, immunohisto chemistry and RNA in situ hybridization methods for recurrent chromosome translocations and gene amplifications in various cancer types.

Non-coding RNA, pseudo genes as new biomarkers in prostate cancer.

Biomarker discovery through application of Next generation sequencing technology.

Molecular cloning and characterization of recurrent chromosome translocations in leukemia, lymphoma and solid tumors.

Application of new high throughput technologies in genome research for the discovery of gene fusions in cancer.

Development of diagnostic reagents based on fluorescence in situ hybridization, immunohisto chemistry and RNA in situ hybridization methods for recurrent chromosome translocations and gene amplifications in various cancer types.

Non-coding RNA, pseudo genes as new biomarkers in prostate cancer.

Biomarker discovery through application of Next generation sequencing technology.

Molecular cloning and characterization of recurrent chromosome translocations in leukemia, lymphoma and solid tumors.

William Cox  attended Pennsbury High School in Yardley, PA, ninth through eleventh grade, then moved to Long Beach Island, N.J. where he attended and graduated from Southern Regional High School in Manahawkin, N.J. He was able to put myself through Juniata College in Huntingdon, PA and Temple Medical School. Following medical school, internship and residency, he  joined the USAF. At the request of the Chair in Pathology at Rhode Island Hospital/Brown University, he developed an educational program in Forensic Pathology and Neuropathology for  the medical students and pathology residents, forensicmd.wordpress.com. According to WordPress this educational blog has been used in 109 countries. The first articles/monographs were posted in September of 2009.

Molecular Biology; Biochemistry of NeurodegenerativeDisorders

Dr. Jianli Dong received her M.D. degree from the First Military Medical University (renamed to Southern Medical University) in Guangzhou, China and her Ph.D. from the Molecular and Medical Genetics Department at University of Toronto, Canada. She did a research postdoc in human genetics at Yale University and a clinical fellowship in molecular genetics at Mount Sinai School of Medicine in New York City. She was Assistant Professor in the Pathology Department at Mount Sinai School of Medicine in New York City before joining University of Texas Medical Branch (UTMB), Galveston, Texas in 2005. Currently she is Professor and Director of Molecular Diagnostics Division in the Pathology Department at UTMB. In recent years she has focused her research effort in 1) RAS-RAF-MEK-ERK and p16-CDK4/6-RB pathways in cancer biology ; 2) Research and development of molecular assays for clinical applications.

RAS-RAF-MEK-ERK and p16-CDK4/6-RB pathways in cancer biology; Research and development of molecular assays for clinical application

Dr. Jay Kalra is a Professor of Pathology in the University of Saskatchewan and has served as Head of the Department of Pathology and Laboratory Medicine, Saskatoon Health Region. He is recognized for his many contributions as a clinical scientist, academic leader and health system administrator. He has been a pioneer in the area of applied biochemistry by establishing the role of oxygen free radicles in the pathophysiology of cardiovascular diseases including heart failure and atherosclerosis and guidelines for thyroid-function testing, laboratory utilization. He has also contributed nationally and internationally in the area of total quality management and lean transformation strategies. He has published extensively and is the author of the book “Medical Errors and Patient Safety: Strategies to reduce and disclose medical errors and improve patience safety.”

·         Ischemia reperfusion Injury – role of oxygen free radicals and antioxidants in various clinical diseases including heart failure and atherosclerosis

·         Quality Care and Patient Safety

·         Laboratory Utilization in Healthcare

·         Medical Error & Disclosure of Adverse Events

·         Total Quality Management in Laboratory Medicine

Dr. Gyanendra Singh has qualified NET-CSIR, NET-ASRB and GATE examinations and earned his Ph.D from Central Drug Research Institute in 2006 and he then moved to USA for pursuing postdoctoral research in areas of microbiology and molecular biology at LSU Health Sciences Center, New Orleans, LA and K-State University, Manhattan, KS, USA. He is an expert in molecular biology, microbiology and virology that can be seen from his publications (> 26) appeared in Journal of Virology, PLoS One, PLoS Pathogens and Journal of Biological chemistry etc.  Presently he is a Scientist in National Institute of Occupational Health an ICMR institute and is also serving as an Editor-In- Chief of the Journal of Metabolomics and Systems Biology as well as Associate Editor of Universal Journal of Biotechnology & Bioinformatics respectively. He has been in the editorial board member of repute journals of international fame.   He has recently been honored with "Young Scientist Award" from Association of Biotechnology & Pharmacy in 2015. He has also been awarded with international fellowship to attend international training course in toxicology in 2016 at Bangkok, Thailand.

Toxicology; Molecular Biology; Virology; Microbiology
 

Dr. Gamil G. S. Zeedan obtained Ph.D. Virology, Cairo University Egypt, MVSCs Virology, and Cairo University, BVSCs, department of Microbiology and Virology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia,2014 -2015 Associate Professor of Microbiology at National Research Center Ministry of High Education - Cairo Egypt -Cairo Egypt, .10-2013 Assistant Professor of Microbiology at Faculty of Medicine and Applied Medical Sciences –Northern Border University (NBU)- KSA) for 3acdemic years 2007- 2010,Assistant Researcher at National Research Center- Ministry of High Education - Cairo Egypt. He teaches the following curriculum, Medical Microbiology and Virology, Diagnostic Microbiology, Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology. 2015- up-to-date Microbiology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia. 2010-52013 Microbiology in faculty of Medicine and Applied medical Sciences - Northern Border University, Saudi Arabia. Participate in teaching Medical Microbiology (Virology) MICM 311 courses for 3rd year Medical students. Participate in teaching Diagnostic Microbiology 1 MLT 341 courses for 3rd year Applied Medical Sciences studentsParticipate in teaching Diagnostic Microbiology 2 MLT342 courses for 3^rd year Applied Medical Sciences students. Participate in teaching Clinical Rotation Microbiology for 4^th year Applied Medical Sciences students. Participate in teaching Clinical Rotation Immunology / Virology for 4^th year Applied Medical Sciences students P.articipate in teaching Medical Microbiology (practical) MICM 311 courses for 3^rd year Medical students.Teaching Diagnostic Microbiology 1 (practical) MLT 341 courses for 3^rd year Applied Medical Sciences students. Participate in teaching Diagnostic Microbiology 2 (practical) MLT342 courses for 3^rd year Applied Medical Sciences student. Training of young doctors in the clinical and laboratory diagnosis of infectious diseases. Diagnosis of hormonal residues in foods. Using of PCR in the diagnosis of animal diseases.- Teaching course of Immunology and Molecular biology for Arab student trainers in NRC, Egypt. Teaching Molecular diagnosis of animals viruses summer training courses sciences student.Organizer and teaching of training Courses " New Molecular Technology in Diagnosis of animals' diseases "Research Experience: Experience in modern & classical Immuno-diagnostic Techniques as different type ELISA , IFAT, RIA, Dot ELISA, HI,CFT,AGPT, SPA agglutination test , SNT & Dot blot hybridization .Diagnosis of animals viruses by different Molecular techniques(different types of PCR ).Teaching Assistant in immunology and Molecular biology Arab student training in NRC , Egypt. Course in the Molecular diagnosis of animals viruses Summer Training courses .Title of supervised projects: Development of a Therapeutic Vaccine against Hepatitis B Virus - Incidence of hepatitis A , B, C ,D and E in Saudi Arabia .The laboratory diagnosis of hepatitis B virus-Human immunodeficiency virus (HIV) infection testing technologies & strategies -Hepatitis C virus virological studies and diagnosis of liver diseases. He published many publications in reputed journals supervising postgraduate students

Molecular Typing; Epidemiological Studies of Viruses and Bactria of Animal Origin with Special Interest of Antibacterial and Antiviral Agents